BT-001, an oncolytic Vaccinia virus armed with a Treg-depletion-optimized recombinant human anti- CTLA4 antibody and GM-CSF to target the tumor microenvironment

Poster BT-001Marchand, Semmrich, Fend et al.
Immuno-Oncology summit
Download the poster here
Poster Presentation